Moreover, increased CD8+ T-cell infiltration and tumor volume reduction was observed in mice treated with a combination of radiotherapy and the CHK1 inhibitor AZD7762 compared with treatments with these agents individually (Chao et al. 2020). This evidence concerns the gene CD8A and neoplasm.